Statistics for High proinsulin: C-peptide ratio identifies patients with Stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab
Total visits
| views | |
|---|---|
| High proinsulin: C-peptide ratio identifies patients with Stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab | 2 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 2 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Sims2023High-AAM.pdf | 7 |